Mar 18, 2015, 10:30 AM by Michael Croft

Bio-IT World News Brief | Ginkgo Bioworks announced this morning that its synthetic biology “foundry,” an 18,000 square foot facility on the Boston waterfront designed to rapidly iterate through new prototypes of genetically modified organisms, is open for business.

Mar 18, 2015, 00:00 AM by Michael Croft

STRASBOURG, FRANCE - Mar 18, 2015 - At the Faculty of Pharmacy of the University of Strasbourg houses (France) a diverse group of research teams work at the interface between chemistry and biology

Mar 17, 2015, 12:45 PM by Michael Croft

Bio-IT World | 23andMe's new drug discovery unit isn't the next disruptive health innovation from Silicon Valley, but it is a good move for a company that should know better than anyone how to turn genetic data into real value.

Mar 17, 2015, 00:00 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC - Mar 17, 2015 - Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, and the University of Florida Department of Medicine have announced an academic collaboration that will help rapidly design and develop novel drugs to inhibit the reproduction of cancer cells

Mar 17, 2015, 00:00 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Mar 17, 2015 - WHAT: Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the Outsourcing in Clinical Trials (OCT) Southeast conference, being held March 24-25 in Cary, North Carolina

Mar 17, 2015, 00:00 AM by Michael Croft

COLUMBUS, OH - Mar 17, 2015 - GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that, through the “Intel Heads In The Clouds Challenge on Amazon Web Services (AWS)” with support from JHC Technology, and in conjunction with Nationwide Children’s Hospital, has benchmarked whole genome sequencing analysis at an unprecedented 1,000 genomes per day

Mar 13, 2015, 00:00 AM by Michael Croft

LOS ANGELES, CA - Mar 13, 2015 - Reprints Desk, Inc., a Research Solutions (OTCQB: RSSS) company and top-rated document delivery supplier for scientific, technical and medical (STM) information, has announced the immediate full-text availability of the article The Ultimate Sophistication: Reprints Desk Launches its Article Galaxy Widget, created by independent research and advisory firm Outsell, Inc

Mar 12, 2015, 14:00 PM by Michael Croft

Mar 12, 2015, 00:00 AM by Michael Croft

Forbes | 23andMe CEO and Founder Anne Wojcicki 23andMe, the Google-backed personal genetics startup, will no longer just sell tests to consumers, or genetic data to pharmaceutical companies. This morning, it announced that it plans to start inventing medicines itself. It's not just talk. The company has hired Richard Scheller, who led drug discovery at Genentech.

Mar 12, 2015, 00:00 AM by Michael Croft

HARDERWIJK, NETHERLANDS - Mar 12, 2015 - Today, biomedical big data solutions company GENALICE and Personalized medicine & biotechnology company Macrogen Inc (CEO Hyonyong Chong) jointly announced that Macrogen has chosen GENALICE MAP to reinforce its big data processing and analysis capacity for large-scale genome analysis and clinical sequencing services

Mar 11, 2015, 09:00 AM by Michael Croft

Mar 11, 2015, 00:00 AM by Michael Croft

DUBAI, UNITED ARAB EMIRATES - Mar 11, 2015 - They say the customer is king. In today’s highly fragmented and competitive markets across sectors, garnering mindshare, especially when it comes to customers who vary greatly according to gender, demographics and purchasing power, to name but a few parameters, is an uphill task

Mar 11, 2015, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Mar 11, 2015 - Aktana, a leader in decision support for global life science sales teams, today announced its status as a Veeva Web Approved Technology Partner, making its proprietary Decision Support Engine more easily available to Veeva CRM customers

Mar 11, 2015, 00:00 AM by Michael Croft

- Mar 11, 2015 - Nowadays, calcium channel blockers, or calcium antagonists, are widely used for treatment of a variety of conditions such as high blood pressure, migraines and Raynaud’s disease

Mar 10, 2015, 12:10 PM by Michael Croft

Bio-IT World News Brief | Illumina has brought another major pharmaceutical partner on board for its Universal Oncology Test program, an effort to build a next-generation sequencing-based gene panel covering all major cancer-related mutations that could be used to select personalized therapies.

Mar 10, 2015, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Mar 10, 2015 - The Intellectual Property and Science business of Thomson Reuters, the world’s leader in intelligent information for businesses and professionals, has unveiled the nominations for the Allicense 2015 Breakthrough Awards, honoring the leading  deals of 2014 in Biopharmaceutical Licensing and  Mergers and Acquisitions (M&A), as identified by Thomson Reuters Recap, the leading provider of analysis and advice for biopharmaceutical business development

Mar 10, 2015, 00:00 AM by Michael Croft

SAN MATEO, CA - Mar 10, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, today announced the appointment of J

Mar 10, 2015, 00:00 AM by Michael Croft

BERLIN, GERMANY - Mar 10, 2015 - Contract Research Organization (CRO), KCR, which operates across 19 European countries as well as the U

Mar 10, 2015, 00:00 AM by Michael Croft

SHIRLEY, NY - Mar 10, 2015 - Although Creative Biogene has already launched a great number of researches on gene expression, recently this biotechnology company is partering with another company in the industry, aiming to make a big step forward in gene expression studies

Mar 9, 2015, 13:00 PM by Michael Croft